Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Weng

Showing results (201-210 of 211) with videos related to

Pageof 22
Sort By:
Biomedicines|March 28, 2026
Factors Affecting Oncological Outcomes in Upper Tract Urothelial Carcinoma Patients with Chronic Kidney Disease and End-Stage Renal DiseaseHung-Keng Li, Hsiang-Ying Lee, Hsin-Chih Yeh, et al.
Journal of Personalized Medicine|February 25, 2022
Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration GroupChung-Yu Lin, Han-Yu Weng, Ta-Yao Tai, et al.
Journal of Clinical Medicine|December 2, 2020
Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in TaiwanLian-Ching Yu, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Frontiers in Oncology|May 9, 2022
Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort AnalysisChi-Wen Lo, Wei-Ming Li, Hung-Lung Ke, et al.
BMC Urology|October 21, 2024
Outcomes of laparoscopic, robotic and open nephroureterectomy with bladder cuff excision in patients with T3T4 upper urinary tract urothelial carcinoma: a multi-center retrospective studyJen-Kai Fang, Hsin-Chih Yeh, Hsiang-Ying Lee, et al.
Scientific Reports|August 12, 2025
Cytoreductive nephroureterectomy for treatment of upper urinary tract urothelial carcinoma initially diagnosed as node-positiveShu-Yu Wu, Chi-Ping Huang, Chao-Hsiang Chang, et al.
The Canadian Journal of Urology|May 5, 2026
Overweight status predicts improved overall survival after radical nephroureterectomy for upper tract urothelial carcinomaShu-Yu Wu, Ching-Chia Li, Wen-Jeng Wu, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
BMC Cancer|April 30, 2025
Development and validation of a prediction model for early recurrence in upper tract urothelial carcinoma treated with radical nephroureterectomyYi-Ju Chou, Hao-Lun Luo, Hung-Jen Wang, et al.
Cell|July 7, 2021
NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanismJennifer Allouche, Inbal Rachmin, Kaustubh Adhikari, et al.
Pageof 22

Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Biomedicines|March 28, 2026
Factors Affecting Oncological Outcomes in Upper Tract Urothelial Carcinoma Patients with Chronic Kidney Disease and End-Stage Renal DiseaseHung-Keng Li, Hsiang-Ying Lee, Hsin-Chih Yeh, et al.
Journal of Personalized Medicine|February 25, 2022
Clinical Efficacy of Adjuvant Chemotherapy in Advanced Upper Tract Urothelial Carcinoma (pT3-T4): Real-World Data from the Taiwan Upper Tract Urothelial Carcinoma Collaboration GroupChung-Yu Lin, Han-Yu Weng, Ta-Yao Tai, et al.
Journal of Clinical Medicine|December 2, 2020
Prognostic Significance of Primary Tumor Location in Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: A Retrospective, Multi-Center Cohort Study in TaiwanLian-Ching Yu, Chao-Hsiang Chang, Chi-Ping Huang, et al.
Frontiers in Oncology|May 9, 2022
Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort AnalysisChi-Wen Lo, Wei-Ming Li, Hung-Lung Ke, et al.
BMC Urology|October 21, 2024
Outcomes of laparoscopic, robotic and open nephroureterectomy with bladder cuff excision in patients with T3T4 upper urinary tract urothelial carcinoma: a multi-center retrospective studyJen-Kai Fang, Hsin-Chih Yeh, Hsiang-Ying Lee, et al.
Scientific Reports|August 12, 2025
Cytoreductive nephroureterectomy for treatment of upper urinary tract urothelial carcinoma initially diagnosed as node-positiveShu-Yu Wu, Chi-Ping Huang, Chao-Hsiang Chang, et al.
The Canadian Journal of Urology|May 5, 2026
Overweight status predicts improved overall survival after radical nephroureterectomy for upper tract urothelial carcinomaShu-Yu Wu, Ching-Chia Li, Wen-Jeng Wu, et al.
Science Translational Medicine|February 18, 2021
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responsesJennifer A Lo, Masayoshi Kawakubo, Vikram R Juneja, et al.
BMC Cancer|April 30, 2025
Development and validation of a prediction model for early recurrence in upper tract urothelial carcinoma treated with radical nephroureterectomyYi-Ju Chou, Hao-Lun Luo, Hung-Jen Wang, et al.
Cell|July 7, 2021
NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanismJennifer Allouche, Inbal Rachmin, Kaustubh Adhikari, et al.
Pageof 22